CannabisNewsBreaks

WednesdayJan 09, 2019 2:17 pm

CBDNewsBreaks – Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) Combining its Thermal Therapy Technology with CBD to Target Chronic Pain

Medical device technology provider Therma Bright (TSX.V: THRM) (OTC: THRBF) is developing an innovative pain relief therapy that utilizes its thermal therapy technology in combination with medical grade cannabis or cannabidiol (“CBD”) from hemp in the form of a cream or gel. A recent article discussing the company reads, “In October, Therma Bright revealed that it is also developing testing for a hemp cannabidiol (CBD)-based pain relief therapy that will use creams, gels or salves in concert with its thermal-generation products to target various forms of general or chronic pain such as back pain, arthritic pain and other orthopedic concerns.…

Continue Reading

WednesdayJan 09, 2019 10:57 am

CBDNewsBreaks – The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) Gains Conditional Approval for Listing on the Toronto Stock Exchange

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) this morning announced that it has received conditional approval from the Toronto Stock Exchange to graduate from the TSX Venture Exchange and list its common shares on the TSX. Final approval of the listing is subject to Supreme Cannabis meeting certain customary conditions required by the TSX, and the company intends to issue an additional statement when the TSX confirms the date on which trading on the TSX will commence. “Graduating to the TSX will broaden our investment appeal and leave us well positioned to execute on our strategic…

Continue Reading

WednesdayJan 09, 2019 9:20 am

CBDNewsBreaks – The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Inks Medical Cannabis Supply Agreement with Shoppers Drug Mart

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), through its subsidiary The Flowr Group (Okanagan) Inc. (collectively “Flowr” or the company), this morning announced its entrance into an agreement with Shoppers Drug Mart, a division of Loblaw Companies Limited (TSX: L), to supply medical cannabis on a purchase order basis. Flowr will supply the leading drug store retailer with its FlowrRx brand of premium medical cannabis products. Initially, the products will be sold online only as Canadian regulations presently restrict the sale of medical cannabis in retail pharmacies, making Shoppers’ new ecommerce site the exclusive direct-to-patient online provider of FlowRx products.…

Continue Reading

TuesdayJan 08, 2019 2:36 pm

CBDNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Proprietary Technology Transforms the Way Molecules Enter the Body

Biotechnology company Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) revolutionary technology, DehydraTECH, alters the way that fat soluble, plant-derived molecules are absorbed into the body. A recent article further discussing the company reads, “Chemicals or intimidating complex ingredients that require disclosure on food labels are not required additions when using DehydraTECH. Instead the edible tech works with commons GRAS ingredients that can be organic and gluten- and dairy-free. It does all of this while still costing partners less than a penny per serving to implement, making DehydraTECH a win-win for the partner and consumer, who both gain from the improved performance…

Continue Reading

TuesdayJan 08, 2019 1:56 pm

CBDNewsBreaks – Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) Focuses on Medical Cannabis, Hemp and CBD-related Companies as Export Laws Begin to Shift in Israel

Redfund Capital (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF), a merchant bank that provides debt and equity funding to mid- and late-stage companies, is currently focusing on medical cannabis, hemp and cannabidiol (“CBD”) related companies. A recent article discussing the company reads, “Recent developments in regulation and research and development in the cannabis space are set to swell the project pipeline of Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4). In November, a government committee in Israel approved the first draft of a law on the export of medical cannabis, a move welcomed by the industry, with one commentator (http://cnw.fm/UmSY8)  opining,…

Continue Reading

TuesdayJan 08, 2019 12:23 pm

CBDNewsBreaks – Youngevity International, Inc. (NASDAQ: YGYI) Subsidiary Ships First 3.8 Million Pounds of Green Coffee Under 5-Year Estimated $250M Contract

Leading omni-direct lifestyle company Youngevity International (NASDAQ: YGYI) this morning announced that its wholly owned subsidiary, CLR Roasters, has, under recent entry of a 5-year contract, begun processing and shipping its first containers of green coffee. The company has already received orders against the contract for 230 containers that are scheduled to ship in the first quarter of this year. Strictly High Grown washed Nicaraguan conventional coffees account for the majority of the initial coffee shipments, while 15 containers of naturals were also included. “We are very pleased to see this contract producing revenue as we kick off 2019,” Youngevity…

Continue Reading

TuesdayJan 08, 2019 11:34 am

CBDNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Applies for Uplisting to OTCQB® Venture Market

Cannabis Strategic Ventures, Inc. (OTC: NUGS) this morning announced that it has submitted its application to uplist to the OTCQB® Venture Market. As noted in the update, the uplisting criteria require the company to file financial and other reports to the Securities & Exchange Commission in a timely manner, in addition to undergoing an extensive verification and certification process. Cannabis Strategic’s management team believes that the company currently meets all of the requirements for a successful uplisting. “We are excited to submit our application to the OTCQB Tier, which has more stringent reporting standards and compliance requirements and requires companies…

Continue Reading

TuesdayJan 08, 2019 11:27 am

CBDNewsBreaks – Earth Science Tech, Inc. (ETST) Enters Strategic Partnerships to Market Hygee, Answer Global Epidemic

Innovative biotechnology company Earth Science Tech (OTCQB: ETST) this morning announced its partnerships with Les Fous de la Com and Priori System communication agencies to promote its Hygee medical device for the self-screening of chlamydia. Per the update, ETST believes that Hygee is the answer to the global epidemic where, according to the Centers for Disease Control, the U.S. alone reported more than 2 million STD cases in 2016, the highest number on record (http://cnw.fm/qvl5V), with Chlamydia accounting for the majority of the cases. Under the agreement, Les Fous de La Com will focus on building a strong online presence…

Continue Reading

TuesdayJan 08, 2019 10:53 am

CBDNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Appoints Two New Directors, Adding Deep Medical and Pharmaceutical Experience to its Board

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today announced appointment of Dr. Caroline MacCallum and Jacques Dessureault to its board of directors. Per the update, Dr. MacCallum is one of the world's most prominent experts in cannabinoid-based medicine. At the University of British Columbia, she is an internist, complex pain and cannabinoid clinician, researcher and clinical instructor in the Department of Medicine, an adjunct professor in the Faculty of Pharmaceutical Sciences Program and an associate member of the Department of Palliative Care. Dr. MacCallum is also Greenleaf Medical Clinic’s medical director, where she…

Continue Reading

TuesdayJan 08, 2019 10:08 am

CBDNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Enters Technology-Focused Cannabis Vertical via Investment in Headset, Inc.; Secures $80M Financial Development for PharmHouse

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning announced its completion of an equity investment in Headset, Inc., a data and analytics service provider for the cannabis industry. Representing its first entry into a technology-focused cannabis vertical, Canopy Rivers subscribed for CAD $4,084,500 of Series A Preferred Shares in Headset. In addition, the company recently announced that its 49 percent-owned joint venture PharmHouse Inc. has entered into a syndicated credit facility with the Bank of Montreal (“BMO”), as agent and lead lender, and with Canadian Imperial Bank of Commerce and Concentra Bank as lenders. According to the update, under the…

Continue Reading